Head-to-head · WeighScore
Jyra Health vs Kina
The verdict
Kina takes it — 69.8/100 to 69.6/100, but only just.
Kina grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Jyra Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Jyra Health | Kina |
|---|---|---|
| WeighScore | 69.6/100 | 69.8/100 |
| Grade | C | C |
| Scorecard rank | #123 | #115 |
| Semaglutide | $99/mo (starting dose, plus a separate fee, compounded) | $179/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $133/mo (starting dose, promotional rate, compounded) | $179/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #123 · C
Strengths
- Among the lowest compounded pricing — semaglutide from $99/mo and tirzepatide from $133/mo, with no membership and no hidden fees
- Board-certified providers in all 50 states; no insurance required and free express delivery
- Offers both compounded semaglutide and tirzepatide, plus a longevity track
- Full legal suite published (Privacy, Terms, HIPAA, Refunds & Cancellations)
Where it loses points
- The $133/mo tirzepatide price is flagged 'limited time' — verify current pricing before enrolling
- Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Zepbound, Ozempic, or Mounjaro
- Displays a self-hosted LegitScript badge but no verifiable seal or listing
- Compounding pharmacy not named; appears to be a newer, smaller clinic (~300 patients/month)
Graded #115 · C
Strengths
- Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- Verifiable LegitScript certification (seal ID 50917967)
- GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Where it loses points
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Built for women navigating menopause — less tailored if that is not your situation
- A separate $50 physician consultation fee applies on top of the medication price
- The compounding pharmacy partner is not named, and the full list of served states is not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.